Speaker illustration

Miss Xinru Ran

The University of Hong Kong, Hong Kong (Hong Kong)

CRISPR/Cas9-mediated correction of Troponin I R186Q mutation rescues myofibrillar disarray and excitation-contraction coupling abnormalities in IPSC model from hypertrophic cardiomyopathy patient

Event: ESC Congress 2018

Topic: Gene Therapy, Cell Therapy

Session: Young Investigator Award Session Basic Science

Thumbnail

Activation of the calcineurin-NFAT pathway in hypertrophic cardiomyopathy due to abnormal calcium homeostasis contributes to progression of cardiomyocytes hypertrophy: Insights from human iPSC model

Event: ESC CONGRESS 2017

Topic: Stem cells and cell therapy

Session: Best Posters in stem cells

Thumbnail

This platform is supported by

logo Novo Nordisk